3,4-Diaminopyridine Phosphate Salt for Sexual Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sexual dysfunction in both males and females are inadequate in enhancing desire and satisfaction, and improving overall sexual life, as they often fail to address the complex biological, psychological, and social factors involved.
Innovation Solution
The use of 3,4-diaminopyridine and its pharmaceutically acceptable salts, such as the phosphate salt, administered orally to treat sexual dysfunction, including disorders like female sexual interest/arousal disorder, male hypoactive sexual desire disorder, and erectile dysfunction, by increasing sexual desire, orgasmic ability, and satisfaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for sexual dysfunction are used, then some symptoms may be addressed, but desire and satisfaction are not enhanced and overall sexual life is not improved
Solution Approach 1:
The patent changes the pharmacological parameter by introducing 3,4-diaminopyridine, a potassium channel blocker, which has different mechanism of action compared to conventional treatments. This drug affects neuronal excitability and signal transmission, thereby improving sexual desire and function without the limitations of existing therapies
2Reliability
If 3,4-diaminopyridine is administered to treat sexual dysfunction, then sexual desire and orgasmic ability are increased, but the mechanism involves complex neuronal and muscular effects that require precise dosing
Solution Approach 1:
The patent employs a standardized pharmaceutical formulation of 3,4-diaminopyridine phosphate salt that can be manufactured as a discrete, pre-dosed medication. This approach simplifies the manufacturing process while ensuring consistent therapeutic effects, making the treatment accessible and reliable for clinical use
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Daily oral administration of 3,4-diaminopyridine phosphate salt has been shown to significantly improve sexual functioning, as evidenced by increased sexual desire, orgasmic ability, and satisfaction in subjects, as measured by standardized questionnaires like the Female Sexual Functioning Index and International Index of Erectile Function.
Implementation Method 1
3,4-Diaminopyridine, also known as amifampridine or 3,4-DAP, is a potassium channel blocker that has been used as a drug in the treatment of a number of rare muscle diseases
Data Source
AI summary
The present disclosure relates to a method of treating female or male sexual dysfunction, wherein the method comprises orally administering to a female or male subject an effective amount of 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof.